jengstrand Profile Banner
jengstrand Profile
jengstrand

@jengstrand

Followers
140
Following
526
Media
0
Statuses
21

Consultant surgeon @KarolinskaUnsju @hpbkarolinska Associate Professor @karolinskainst

Stockholm, Sverige
Joined August 2020
Don't wanna be here? Send us removal request.
@jengstrand
jengstrand
1 day
Final Call: Share Your Expertise on Synchronous CRLM 🌍 HPB and colorectal surgeons We need your input on treatment strategies, current practice and challenges 🕝 One week left Link 👉 https://t.co/MlRpjIDk8L @sparrelid @ksoreide @EAHPBA @IHPBA #colorectal #HPB
Tweet card summary image
docs.google.com
Dear Colleague, We are conducting an international survey to document the real-world perspectives and practices of surgeons and oncologists in the management of synchronous colorectal liver metasta...
0
4
6
@EAHPBA
E-AHPBA
9 days
Join us this Thursday! 🔗 Register now:
@EAHPBA
E-AHPBA
20 days
🚨 Join the next E-AHPBA Grand Rounds! 📅 Thursday 23rd October 2025, 18:00 CET 🎯 Topic: Colorectal Liver Metastases 🧑‍⚕️ Speakers: Rene Adam @IHPBA President, Sheraz Yaqub & Jennie Engstrand #MedicalEducation Don’t miss this session in the E-AHPBA Online Academy Certificate
0
7
12
@EAHPBA
E-AHPBA
20 days
🚨 Join the next E-AHPBA Grand Rounds! 📅 Thursday 23rd October 2025, 18:00 CET 🎯 Topic: Colorectal Liver Metastases 🧑‍⚕️ Speakers: Rene Adam @IHPBA President, Sheraz Yaqub & Jennie Engstrand #MedicalEducation Don’t miss this session in the E-AHPBA Online Academy Certificate
0
11
27
@sparrelid
Ernesto Sparrelid
19 days
Please help us better understand current management of synchronous CRLM by taking this @EAHPBA endorsed survey by @jengstrand from @HpbKarolinska A special plea to our colorectal surgeon & GI onc colleagues, help us disseminate this in your network 👉 https://t.co/UsfgZuBjrr
0
9
11
@sparrelid
Ernesto Sparrelid
9 months
Do you recognize ciliated hepatic foregut cysts (CHFC) at your center? For you who do, what is your treatment policy? Full article: Ciliated hepatic foregut cysts: a large retrospective single-centre series https://t.co/SGoTEfjn30 @dr_gilgson @jengstrand @HpbKarolinska @hpb_so
3
3
8
@BjsOpen
BJS Open
1 year
Importance of resection margin after resection of colorectal liver metastases in the era of modern chemotherapy: population-based cohort study ➡️ https://t.co/2WFFs8zv9W This national study examines how resection margins of 0.0 mm, 0.1–0.9 mm and ≥1 mm influence overall survival
1
27
43
@PancreasGroup
PancreasGroup.org
2 years
🚨 https://t.co/ogKjVuJEID 2 💡Survey on Hospital Factors Affecting Failure to Rescue in Pancreatic Surgery Participate now! 👉 https://t.co/wYFpvyqMut ✅ Complete the online Survey ⏰10min ✅ Stay anonymous ✅ No need for ethics approval ✅ PubMed citable co-authorship
0
8
12
@Cancer_Invasion
Cancer Cell Invasion lab
3 years
Why are some metastases more aggressive than others? In a new manuscript, we got a little closer to the answer by taking a good look at the fibrotic capsule that surrounds some liver metastases - this one is really close to the lab's heart! 1/8: https://t.co/Mc2GqyoOzS
1
11
26
@BJSurgery
BJS
2 years
Comparing the accuracy of prediction models to detect clinically relevant post-hepatectomy liver failure early after major hepatectomy ➡️ https://t.co/Ll9cE3NCJM Arterial lactate measurements were recently suggested as an early predictor of clinically relevant post-hepatectomy
0
17
39
@sparrelid
Ernesto Sparrelid
2 years
Superb defence today by Pascale Tinguely! @karolinskainst Great opposition and discussion by @AAFretland from @Oslounivsykehus @jengstrand from @HpbKarolinska part of the supervisor group. Important work on MWA for CRLM @hpb_so @EAHPBA
2
11
41
@AAFretland
Åsmund A. Fretland
2 years
Ablation on the big stage #eahpba2023. Jacob Freedman @Danderydssjukh @karolinskainst with a solid overview. Great discussion by @VautheyMD. RCTs are coming! @jengstrand @PascalePasci central in the scientific work! @sparrelid @dr_gilgson @EAHPBA
0
7
27
@jengstrand
jengstrand
3 years
💎 MAVERRIC trial is out 💎 Stereotactic MWA, a valid treatment option for resectable CRLM? 🇸🇪🇳🇱🇨🇭98 patients 🤜🤛 SMWA vs HR 👍 equal 3yr survival ⬇️ morbidity @PascalePasci AddThis | Home
0
12
36
@BjsOpen
BJS Open
3 years
#ICYMI: Popular BJSOpen papers online in 2022 July: Post-hepatectomy liver failure & survival 🧑‍🤝‍🧑799 pts/27% liver failure Grade A PHLF 🔼comps, no impact on 90d mortality Grade B/C 🔼90day mortality Survive to 90 days, no longterm impact #some4surgery https://t.co/59pXZGFc0u
0
4
5
@sparrelid
Ernesto Sparrelid
3 years
Attention @hpb_so #some4HPB! Our second HPB fellowship @HpbKarolinska @KarolinskaUnsju @karolinskainst is now ready for applicants. Deadline December 15, starting in September 2023. Current fellow is @Giampaolo_Perri from @PancreasVerona
2
41
104
@ejsotweets
European Journal of Surgical Oncology
3 years
Ablation versus resection for resectable colorectal liver metastases - Health care related cost and survival analyses from a quasi-randomised study #MAVERRIC trial @karolinskainst @researchumcg @ESSOnews @AHPBA @OncologyAdvance @deLiguoriCarino @hpb_so https://t.co/Cc2dkKxBxo
0
3
2
@jengstrand
jengstrand
3 years
MWA 🤜🤛Liver resection for resectable CRLM 🌸equal 5yr OS 🌸morbidity & LOS ⬇️ following MWA 🌸💸⬇️ after MWA ⚠️small study: egarly awaiting results from RCT
0
6
20
@Cancer_Invasion
Cancer Cell Invasion lab
3 years
Guess what we are working on now! Big thanks to all diligent scientists, clinicians & collaborators involved, @sparrelid @jengstrand @AndreaCdelVall1 @HonigNatalie @Juniperan, Peter Vermeulen, Carlos Fernández Moro et al (not on twitter)! 8/8
0
2
5
@sparrelid
Ernesto Sparrelid
4 years
Glad to present our new HPB fellowship @HpbKarolinska Deadline for applying to the first fellowship starting september 2022 is February 13. Please follow the link below for more details and share with retweet. @karolinskainst @KarolinskaUnsju @hpb_so https://t.co/2AFPcQ1Yp9
Tweet card summary image
dropbox.com
Shared with Dropbox
3
32
67
@BjsOpen
BJS Open
4 years
What happens with #surgical treatment of #liver #metastases in #scc? 102 patients 56 anal scc + 46 non anal scc Median survival with resection or ablation: 50 months and 21 months respectively. Interesting. #openaccess #SoMe4Surgery Read it here: https://t.co/5RjOs4yVDG
2
4
11